Session 116 - 12th CROI

Home

Session 116 Poster Abstracts
Transmission of HIV Drug Resistance
Wednesday, 1:30 - 3:30 pm
Hall A

670	Setting the Stage for Transmission of Drug Resistance:Genital HIV Shedding and Drug Resistance in Men and Women David Katzenstein*¹, M Winters¹, S Fiscus², L Petch², D Bettendorf³, R Bosch³, M Cooper³, S Cu-Uvin⁴, R D'Aquila⁵, E Mowry⁵, A Luque⁶, L Frenkel⁶, N Ellis⁶, W Cavert⁷, R Coombs⁶, and ACTG A5077 Study Team. NIH, NIAID, DAIDS, Bethesda, MD ¹Stanford Univ, CA, USA; ²Univ of North Carolina at Chapel Hill, USA; ³Harvard Sch of Publ Hlth, Boston, MA, USA; ⁴Brown Univ Sch of Med, Providence, RI, USA; ⁵Vanderbilt Univ, Nashville, TN, USA; ⁶Univ of Washington, Seattle, USA; and ⁷Univ of Minnesota, Minneapolis, USA
671	Prevalence and Persistence of NNRTI Mutations In the Female Genital Tract Michael Newstein*¹, T Martin¹, P Losikoff¹, A Caliendo², J Ingersoll², J Kurpewski¹, D Hanley¹, J Cerezo¹, B Ramratnam¹, and S Cu-Uvin¹ ¹Brown Univ Sch of Med, Providence, RI, USA and ²Emory Univ, Atlanta, GA, USA
672	Transmission of Drug-resistant Viruses in Recent HIV Seroconverters in Spain Carmen de Mendoza*¹, C Rodriguez², J Colomina³, C Tuset⁴, F Garcia⁵, J Eiros⁶, A Corral¹, J del Romero², J Aguero⁷, P Leiva⁸, J Torre-Cisneros⁹, I Viciana¹⁰, J Pedreira¹¹, R Ortiz¹², V Soriano¹, and on behalf of the Spanish Seroconverter Study Group. ¹Hosp Carlos III, Madrid, Spain; ²Ctr Sanitario Sandoval, Madrid, Spain; ³Hosp de la Ribera, Valencia, Spain; ⁴Hosp Clin, Valencia, Spain; ⁵Hosp San Cecilio, Granada, Spain; ⁶Hosp Univ, Valladolid, Spain; ⁷Hosp Marques de Valdecilla, Santander, Spain; ⁸Hospital Central de Asturias, Oviedo, Spain; ⁹Hosp Reina Sofia, Cordoba, Spain; ¹⁰Hosp Virgen de la Victoria, Malaga, Spain; ¹¹Hosp Juan Canalejo, A Coruña, Spain; and ¹²Hosp Clin, Valladolid, Spain
673	Transmitted HIV Resistance among Patients with Acute and Recent HIV Infection in North Carolina: Report of 102 Cases Charles Hicks*¹, J Eron², S Fiscus², L Petch², T Nguyen², P Menezes², J Giner¹, P Leone², A Cachafeiro³, B Stalzer³, D Williams³, T McPherson³, J Sebastian⁴, and C Pilcher² ¹Duke Univ Med Ctr, Durham, NC, USA; ²Univ of North Carolina at Chapel Hill, USA; ³North Carolina Dept of Hlth and Human Svcs, Raleigh, USA; and ⁴LabCorp, Burlington, NC, USA
674	U.S. Surveillance of HIV Drug Resistance at Diagnosis Using HIV Diagnostic Sera Diane Bennett*¹, L McCormick², R Kline², W Wheeler², M Hemmen², A Smith¹, I Zaidi¹, T Dondero¹, and The HIV Drug Resistance ARVDRT/VARHS Surveillance Group ¹CDC, Atlanta, GA, USA and ²Northrup Grumman, Atlanta, GA, USA
675	Evolution of Resistant HIV-1 Strains after Transmission Daniela Bezemer*^1,3, A de Ronde², M Prins³, N Back², B Berkhout², L van der Hoek², and CASCADE ¹Univ of Amsterdam, The Netherlands; ²Academic Med Ctr, Univ of Amsterdam, The Netherlands; and ³Municipal Hlth Svc, Amsterdam, The Netherlands